Clinical Trial Update: Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating human umbilical cord-derived mesenchymal stem cells for pneumoconiosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumoconiosis

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shenzhen Hornetcorn Bio-technology Company, LTD | Conditions: Pneumoconiosis | Phase 1 | Status: UNKNOWN